Pharmacogenetics and cancer chemotherapy

This publication has 108 references indexed in Scilit:

• A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency
  Journal of Inherited Metabolic Disease, 1996
• Genetic variation of CNS receptors - a new perspective for pharmacogenetics
  Pharmacogenetics, 1995
• Specificity of human UDP-Glucuronosyltransferases and xenobiotic glucuronidation
  Life Sciences, 1995
• Human Polymorphism in Drug Metabolism: Mutation in the Dihydropyrimidine Dehydrogenase Gene Results in Exon Skipping and Thymine Uracilurea
  DNA and Cell Biology, 1995
• Pharmacogenetics: detecting sensitive populations.
  Environmental Health Perspectives, 1994
• Dihydropyrimidine dehydrogenase activity in cancer patients
  European Journal Of Cancer, 1993
• Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6‐mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia
  British Journal of Clinical Pharmacology, 1993
• Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia
  The Journal of Pediatrics, 1991
• Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil Toxicity
  New England Journal of Medicine, 1985
• Variable Bioavailability of Oral Mercaptopurine
  New England Journal of Medicine, 1983